Reiner Heiken, Chief Executive Officer, Hellmann Worldwide Logistics, said: “The pharma and healthcare industry has never been more important than it is today. To ensure that vital products such as vaccines and other life-saving pharmaceutical products are handled with the highest integrity and safety, we have globally established Hellmann Healthcare Logistics. People, processes, infrastructure and digitalization are the foundation of our healthcare network and enable us to offer compliant, transparent and innovative transportation and distribution solutions. Combining a risk-based approach and integration of secured digital solutions into supply chains, Hellmann offers qualified end-to-end transport with capabilities of real-time and proactive intervention.”
He added: “In the Middle East, Hellmann Healthcare Logistics gained a leadership position by operating a proven-and-tested hub concept for more than a decade, using UAE healthcare warehouses as distribution platforms for the region. Our specialized regional and global experience will be complimentary to the strength of the Hope Consortium partners. Together we stand ready to support the UAE and Abu Dhabi Governments in leading efforts for the global distribution of the SARS-CoV2 vaccines.”
With over 78,000 employees at 1,400 locations in over 100 countries, the Kuehne+Nagel Group is one of the world’s leading logistics companies. In 2019, the company moved 4.9 million twenty-foot equivalent units (TEUs) by sea freight, 1.6 million tons by air freight, operated 32,500 truck departures a day in Europe and managed 11.4 million square metres of logistics and warehousing space.
Robert Coyle, Senior Vice President, Pharma & Healthcare Strategy, at Kuehne+Nagel, noted: “As one of the global leaders in Pharma & Healthcare logistics, Kuehne+Nagel have the capacity, the ability and responsibility to facilitate the global distribution of SARS-CoV-2 vaccines and supporting materials with global stakeholders. By joining Hope Consortium, we bring in the Kuehne+Nagel CEIV accredited global network of cool facilities, long-standing experience of large vaccine shipments and dedicated Pharma and Healthcare specialists that will ensure fast, safe and secure transportation. We will leverage our unique strengths in the vaccine supply chain and facilitate vaccine availability across the world. We will make it happen.”
This signing will be the first of many to come to ensure that no location is too far and no logistical challenge too difficult for the safe and effective delivery of SARS-CoV-2 vaccine doses.
